Galectin therapeutics CFO sells shares for $56,053
NeutralFinancial Markets

The CFO of Galectin Therapeutics has sold shares worth $56,053. This transaction is part of regular financial activities within the company.
Editor’s Note: This sale may indicate the CFO's personal financial strategy or could be part of a broader trend in the company's stock activity. Understanding such transactions can provide insights into the company's financial health and investor sentiment.
— Curated by the World Pulse Now AI Editorial System